Integrating Multi-Cancer Early Detection (MCED) Tests with Standard Cancer Screening: System Dynamics Model Development and Feasibility Testing
The clinical utility and outcomes of MCED testing for screening and early detection still lack comprehensive evidence. Nonetheless, this simulation model facilitates a thorough analysis of MCED tests within the Australian healthcare context, providing insights into potential additional detections and costs to the healthcare system, which may help prioritise future evidence development. The adaptable yet novel SD model presented herein is anticipated to be of considerable interest to industry, policymakers, consumers and clinicians involved in informing clinical and economic decisions regarding integrating MCED tests as cancer screening and early detection tools. The expected results of applying this SD model will determine whether using MCED testing in conjunction with SOC screening offers any potential benefits, possibly guiding policy decisions and clinical practices towards the adoption of MCED tests.
Authors
- Maarten J. IJzerman (ORCID: https://orcid.org/0000-0001-5788-5805)
- Hadi Akbarzadeh Khorshidi (ORCID: https://orcid.org/0000-0002-2653-4102)
- Özge Karanfil (ORCID: https://orcid.org/0000-0002-2319-0818)
- Stephen Q. Wong (ORCID: https://orcid.org/0000-0002-7335-2168)
- Jon Emery (ORCID: https://orcid.org/0000-0002-5274-6336)
- Mussab Fagery (ORCID: https://orcid.org/0000-0003-4095-8590)
Institutions
- Koç University (TR)
- The University of Melbourne (AU)
- Peter MacCallum Cancer Centre (AU)
- Melbourne Health (AU)
- Erasmus University Rotterdam (NL)
Publication Details
- Journal
- PharmacoEconomics - Open
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1007/s41669-024-00533-3
- Citations
- 3
- Primary Topic
- Genetics, Bioinformatics, and Biomedical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.70